Syngene International expands ongoing collaboration with Bristol-Myers Squibb

14 Nov 2017 Evaluate

Syngene International has expanded its ongoing collaboration with Bristol-Myers Squibb. The next phase of the partnership will see the addition of a new facility to support future Bristol-Myers Squibb research and development operations, an expansion of the team and the extension of the existing agreement through 2026. The expansion will enable the two companies to undertake a greater range of scientific research and development for pharmaceuticals across a broader range of activities.

As part of the expansion, Syngene will set up a new dedicated facility spread across 25,000 square feet of laboratory and office space for Bristol-Myers Squibb. This facility will house an additional team of 75 Syngene scientists who will work exclusively in support of Bristol-Myers Squibb.

Syngene International is India’s largest Contract Research Organization providing integrated discovery and development services for novel molecules across multiple platforms including small molecules, large molecules, Antibody-Drug Conjugates and Oligonucleotides.


Syngene Internation. Share Price

627.15 -2.85 (-0.45%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 627.15
Indegene 496.50
CMS Info Systems 331.05
Sagility 53.50
Smartworks Coworking 462.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×